These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


483 related items for PubMed ID: 1978842

  • 1. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM.
    J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [Abstract] [Full Text] [Related]

  • 2. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 3. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM.
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [Abstract] [Full Text] [Related]

  • 4. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM, Dajani EZ.
    J Assoc Acad Minor Phys; 1992 Oct; 3(4):142-8. PubMed ID: 1392409
    [Abstract] [Full Text] [Related]

  • 5. Drugs for treatment of peptic ulcers.
    Dajani EZ, Trotman BW.
    J Assoc Acad Minor Phys; 1992 Oct; 3(3):78-88. PubMed ID: 1353999
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 7. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep 29; 20(119):216-9. PubMed ID: 21954519
    [Abstract] [Full Text] [Related]

  • 8. Management of NSAID-induced ulcer disease.
    Clearfield HR.
    Am Fam Physician; 1992 Jan 29; 45(1):255-8. PubMed ID: 1728095
    [Abstract] [Full Text] [Related]

  • 9. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK.
    J Fam Pract; 1994 Jan 29; 38(1):60-7. PubMed ID: 8289053
    [Abstract] [Full Text] [Related]

  • 10. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Miller DR.
    Clin Pharm; 1992 Aug 29; 11(8):690-704. PubMed ID: 1511542
    [Abstract] [Full Text] [Related]

  • 11. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK, Sung JJ.
    Best Pract Res Clin Gastroenterol; 2001 Jun 29; 15(3):433-45. PubMed ID: 11403537
    [Abstract] [Full Text] [Related]

  • 12. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 29; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 13. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
    Zfass AM, McHenry L, Sanyal AJ.
    Gastroenterologist; 1993 Jun 29; 1(2):165-9. PubMed ID: 8049889
    [Abstract] [Full Text] [Related]

  • 14. Medical treatment of peptic ulcers.
    Deveney CW, Deveney KE.
    Surg Annu; 1985 Jun 29; 17():219-33. PubMed ID: 3883541
    [Abstract] [Full Text] [Related]

  • 15. Peptic ulcers in the elderly: unique features and management.
    Freston MS, Freston JW.
    Geriatrics; 1990 Jan 29; 45(1):39-42, 45. PubMed ID: 2403956
    [Abstract] [Full Text] [Related]

  • 16. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM.
    Eur J Rheumatol Inflamm; 1993 Jan 29; 13(1):17-24. PubMed ID: 7821335
    [Abstract] [Full Text] [Related]

  • 17. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 Jan 29; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 18. NSAID-induced gastrointestinal toxicity.
    Simon LS, Goodman T.
    Bull Rheum Dis; 1995 May 29; 44(3):1-5. PubMed ID: 7767404
    [Abstract] [Full Text] [Related]

  • 19. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R, Armstrong D.
    Can J Gastroenterol; 1999 Mar 29; 13(2):135-42. PubMed ID: 10203432
    [Abstract] [Full Text] [Related]

  • 20. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM, Saggioro A.
    J Rheumatol Suppl; 1991 Mar 29; 28():15-8. PubMed ID: 1674754
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.